Amanote Research
Register
Sign In
The Impact of Treatment-Free Remission of Tasigna® for CML Patients in China – A Cost Effectiveness Analysis
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.221
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
S Chen
JW Xuan
Y Zhang
H Zhu
J Luo
J Tan
C Liu
M Qiu
S Qu
T Xiong
Publisher
Elsevier BV
Related search
CXorf48 Is a Potential Therapeutic Target for Achieving Treatment-Free Remission in CML Patients
Blood Cancer Journal
Oncology
Hematology
Oseltamivir Treatment for Children With Influenza-Like Illness in China: A Cost-Effectiveness Analysis
PLoS ONE
Multidisciplinary
Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Pharmalgen® for the Treatment of Bee and Wasp Venom Allergy.
Health Technology Assessment
Medicine
Health Policy
Cost-Effectiveness Analysis of Adjuvant Treatment for Resected Pancreatic Cancer in China Based on the ESPAC-4 Trial
Cancer Management and Research
Oncology
Cost-Effectiveness Analysis of Celecoxib in the Treatment of Patients With Chronic Pain in Japan
Iryo To Shakai
Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment in Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd66 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Cyprus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
